Richard Peters - Net Worth and Insider Trading

Richard Peters Net Worth

The estimated net worth of Richard Peters is at least $170,153 dollars as of 2024-11-13. Richard Peters is the President and CEO of Yumanity Therapeutics Inc and owns about 90,028 shares of Yumanity Therapeutics Inc (YMTX) stock worth over $170,153. Details can be seen in Richard Peters's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Richard Peters has not made any transactions after 2022-12-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Richard Peters

To

Richard Peters Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Richard Peters owns 4 companies in total, including Aprea Therapeutics Inc (APRE) , Merrimack Pharmaceuticals Inc (MACK) , and Yumanity Therapeutics Inc (YMTX) among others .

Click here to see the complete history of Richard Peters’s form 4 insider trades.

Insider Ownership Summary of Richard Peters

Ticker Comapny Transaction Date Type of Owner
APRE Aprea Therapeutics Inc 2020-06-26 director
MACK Merrimack Pharmaceuticals Inc 2017-02-06 director & President and CEO
YMTX Yumanity Therapeutics Inc 2022-12-02 director & President & CEO
LIMIT LIMIT 2020-12-22 director & President & CEO

Richard Peters Latest Holdings Summary

Richard Peters currently owns a total of 1 stock. Richard Peters owns 90,028 shares of Yumanity Therapeutics Inc (YMTX) as of December 2, 2022, with a value of $170,153.

Latest Holdings of Richard Peters

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
YMTX Yumanity Therapeutics Inc 2022-12-02 90,028 1.89 170,153

Holding Weightings of Richard Peters


Richard Peters Form 4 Trading Tracker

According to the SEC Form 4 filings, Richard Peters has made a total of 4 transactions in Yumanity Therapeutics Inc (YMTX) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Yumanity Therapeutics Inc is the sale of 10,890 shares on December 2, 2022, which brought Richard Peters around $18,404.

Insider Trading History of Richard Peters

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Richard Peters Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Richard Peters Ownership Network

Ownership Network List of Richard Peters

No Data

Ownership Network Relation of Richard Peters

Insider Network Chart

Richard Peters Owned Company Details

What does Aprea Therapeutics Inc do?

Who are the key executives at Aprea Therapeutics Inc?

Richard Peters is the director of Aprea Therapeutics Inc. Other key executives at Aprea Therapeutics Inc include President & CEO Oren Gilad , SrVP/CFO/Prin. Fin &Acctg. Off John P. Hamill , and director & President & CEO Christian S Schade .

Aprea Therapeutics Inc (APRE) Insider Trades Summary

Over the past 18 months, Richard Peters made no insider transaction in Aprea Therapeutics Inc (APRE). Other recent insider transactions involving Aprea Therapeutics Inc (APRE) include a net purchase of 3,900 shares made by Oren Gilad , a net purchase of 26,957 shares made by Bernd R. Seizinger , and a net purchase of 23,728 shares made by Marc Duey .

In summary, during the past 3 months, insiders sold 6,462 shares of Aprea Therapeutics Inc (APRE) in total and bought 42,590 shares, with a net purchase of 36,128 shares. During the past 18 months, 6,462 shares of Aprea Therapeutics Inc (APRE) were sold and 69,417 shares were bought by its insiders, resulting in a net purchase of 62,955 shares.

Aprea Therapeutics Inc (APRE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Aprea Therapeutics Inc Insider Transactions

No Available Data

Richard Peters Mailing Address

Above is the net worth, insider trading, and ownership report for Richard Peters. You might contact Richard Peters via mailing address: Merrimack Pharmaceuticals, Inc., One Kendall Square, Suite B7201, Cambridge Ma 02139.